Eevia Health Plc has received a EUR 47,000 sales order from a European nutraceutical brand owner with delivery in December 2023. The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements, as well as cosmetics in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA.

The purchase order is a repeat order with a sales value to Eevia of c. EUR 47,000 for delivery in December. Eevia has the product in stock. The product is Feno-Myrtillus®?

1, a Bilberry extract standardized for anthocyanins. This is one of the customers Eevia services directly without using a distributor. The business has developed over the last few years, with growing repeat orders.

Eevia is selected due to the high quality and authenticity of the product.